Skip to main content

Table 1 Characteristics of ovarian cancer patients and control groups: benign ovarian tumor and healthy subjects

From: The plasma concentration of VEGF, HE4 and CA125 as a new biomarkers panel in different stages and sub-types of epithelial ovarian tumors

Study group   Number of patients
Epithelial ovarian cancer patients   100 (100%)
• median age (range)   59 (46–87)
- sub-type serous epithelial   54 (54%)
• median age (range)   59 (46–81)
- sub-type endometrioid epithelial   46 (46%)
• median age (range)   59 (49–87)
Tumor stage IA-T1aN0M0 5 (5%)
IB-T1bN0M0 7 (7%)
IC-T1cN0M0 13 (13%)
IIA-T2aN0M0 8 (8%)
IIB-T2bN0M0 9 (9%)
IIC-T2cN0M0 8 (8%)
IIIA-T3aN0M0 9 (9%)
IIIB-T3bN0M0 9 (9%)
IIIC-T3cN0M0 7 (7%)
IV(metastases) 25 (25%)
Menopausal status:   
- postmenopausal   100 (100%)
Benign ovarian tumor patients   80 (100%)
- type cystis serous   40 (50%)
- type cystis endometriosis   40 (50%)
Median age (range)   54 (48–68)
Menopausal status:   
- postmenopausal   80 (100%)
Healthy subjects   50 (100%)
Median age (range)   55 (47–64)
Menopausal status:   
- postmenopausal   50 (100%)